DIFFICULTIES OF IN VIVO DIAGNOSIS OF WEGENER'S GRANULOMATOSIS IN INFECTIOUS (COVID-19) HOSPITAL

Author(s):  
R.V. Myakonky ◽  
K.O. Kaplunov ◽  
S.I. Krayushkin ◽  
I.I. Hasanov ◽  
A.A. Dudkyna
1994 ◽  
Vol 45 (4) ◽  
pp. 1120-1131 ◽  
Author(s):  
Elisabeth Brouwer ◽  
Minke G. Huitema ◽  
A.H. Leontine Mulder ◽  
Peter Heeringa ◽  
Harry van Goor ◽  
...  

1987 ◽  
Author(s):  
L Chrobák ◽  
V Rozsíval ◽  
V Herout

In a 23-year-old man with Wegener’s granulomatosis and mild bleeding coagulation studies revealed a significant prolongation of the coagulation time (CT) prothrombin time (PT), activated partial thromboplastin time (aPTT), thrombin time (TT), failure of TT and aPTT to correct in a 1:1 mixture with pooled normal plasma (PNP), correction of the prolonged TT with toluidine blue and correction of TT and aPTT both in vitro and in vivo^protamine sulphate (P.S.).All other coagulation tests, i.e.,bleeding time, platelet count? fibrinogen level, euglobulme lysis time were within normal limits. The patient did not receive heparine. TT after administration of 5ml of protamine sulphate i.v. to the patient became normal - 18,2 s (19,7 s).In summary a patient with Wegener s granulomatosis associated with an endogenous heparine-like anticoagulant is reported. The anticoagulant could be corrected both in vitro and in vivo by protamine sulphate.


2006 ◽  
Vol 146 (3) ◽  
pp. 455-462 ◽  
Author(s):  
A.-I. Kälsch ◽  
W. H. Schmitt ◽  
A. Breedijk ◽  
S. Marinaki ◽  
S. Weigerding ◽  
...  

2015 ◽  
Vol 4 (1) ◽  
pp. 27-29
Author(s):  
Doğan ATAN ◽  
Ayşe Betül TOPAK ◽  
Kürşat Murat ÖZCAN ◽  
Mehmet Ali ÇETİN ◽  
Serdar ENSARİ ◽  
...  

1997 ◽  
Vol 40 (7) ◽  
pp. 1354-1360 ◽  
Author(s):  
Phot Luisiri ◽  
Nancy Joseph Lance ◽  
James J. Curran

Sign in / Sign up

Export Citation Format

Share Document